Executive Summary
The 7 filings highlight a surge in NCLT-driven restructuring activities, including demergers, amalgamations, capital reductions, and ongoing CIRP under IBC, with 4/7 involving direct NCLT approvals or applications as of late March 2026. Key period-over-period trend: Lactose India posted modest FY25 revenue growth of 2.2% YoY to ₹11,640 lakhs but PAT declined 24% YoY to ₹516 lakhs, contrasting VIPL's deepening losses (PAT -₹196 lakhs on ₹35 lakhs revenue); no other explicit YoY/QoQ data but schemes address legacy losses (e.g., Charms P&L debit wipeout). High consents dominate (96-100% from shareholders/creditors in KMSugar, Charms, Lactose), signaling stakeholder support for value unlock amid neutral/mixed sentiments (1 positive, 1 mixed, 5 neutral). Critical developments: Imminent EGMs (Lactose Mar28, Torrent Apr28) and appointed dates (KMSugar Apr1) create near-term catalysts, while Ansal's prolonged CIRP flags realty distress. Portfolio implications: Restructuring wave offers turnaround potential but with dilution/integration risks; monitor pharma/chemicals for capacity synergies vs real estate insolvency drag.
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from March 26, 2026.
Investment Signals(11)
- K.M. Sugar Mills↓(BULLISH)▲
NCLT approved Distillery demerger (Rectified Spirit/Ethanol) into wholy-owned sub with 96.23% secured creditor consent, 100% equity/unsecured approval, and 1:5 share ratio for independent listing
- K.M. Sugar Mills↓(BULLISH)▲
Dispensation of meetings granted due to high consents (96-100%), board approved Aug2025 with NSE/BSE no-objections Jan2026, unlocking sharper focus/efficiency
- Lactose India↓(BULLISH)▲
FY25 revenue +2.2% YoY to ₹11,640 lakhs despite PAT -24% YoY, merger adds 5,000 MT capacity (+50% to 15,000 MT p.a.) via VIPL synergies
- Charms Industries↓(BULLISH)▲
NCLT approved equity capital reduction (₹4.1Cr to ₹41L, face value ₹10 to ₹1) + reserve cancellation to wipe ₹4Cr P&L debit, 25/26 shareholders approved Sep2024
- Charms Industries↓(BULLISH)▲
No secured creditors (as of Nov2024), regulators (ROC/IT/SEBI) no-objections, cleans BS post-RBI license cancel (Jul2021) despite MCA watchlist history
- Torrent Pharmaceuticals↓(BULLISH)▲
NCLT Ahmedabad ordered Apr28 2026 shareholders meeting for JB Chemicals amalgamation, backed by EY/BDO valuation (Jun2025) + Axis/ICICI fairness opinions
- Refex Industries↓(BULLISH)▲
NCLT Chennai application filed Mar26 2026 for composite scheme (Refex Green Mobility into Refex Industries/Refex Mobility), following Sep2025/Mar2026 intimations
- Ansal Properties↓(NEUTRAL)▲
50th COC meeting Mar23 2026 ratified CIRP expenses for Fernhill Project, NCLAT confined to specific projects post-settlements (IL&FS/Serene)
- Lactose India↓(MIXED)▲
Promoter holding rises 5.19% to 58.84% post-merger (0.7946:1 swap), 100% consents from equity/unsecured but EGM Mar28 via VC/OAVM
- Lactose India (EGM Notice)(NEUTRAL)▲
Corrigendum published Mar27 2026 in Business Standard/Vadodara Samachar, full compliance with SEBI LODR 30/47(3) for merger EGM
- Charms Industries↓(NEUTRAL)▲
Ceased money-changing post-RBI cancel but regular MCA filings past 5 years, 4 unsecured creditors claims ₹51L
Risk Flags(8)
- Lactose India/Financial Deterioration↓[HIGH RISK]▼
FY25 PAT -24% YoY to ₹516 lakhs despite +2.2% revenue YoY, EBITDA ₹1,841 lakhs under pressure
- Lactose India/Merger Counterparty↓[HIGH RISK]▼
VIPL PAT loss ₹196 lakhs on ₹35 lakhs revenue (deepening losses), integration risks + business disruptions flagged
- Lactose India/Dilution↓[MEDIUM RISK]▼
Public shareholding dilutes 5.19% (46.35% to 41.16%), promoter group up to 58.84% via 20L VIPL shares + 0.7946:1 swap
- Ansal Properties/Prolonged CIRP↓[HIGH RISK]▼
50th COC meeting (Mar23 2026) for Fernhill Project ongoing since NCLT admission Nov2022, NCLAT confines but expenses ratify signals delays
- Charms Industries/Legacy Issues↓[MEDIUM RISK]▼
P&L debit ₹4Cr from capital unrepresented by assets, ex-money changer (RBI license cancel Jul2021), prior MCA vanishing company watchlist
- Charms Industries/Creditor Exposure↓[MEDIUM RISK]▼
4 unsecured creditors hold ₹51L claims (Nov2024), no secured but adjustment via capital reduction
- Lactose India/EGM Execution↓[LOW RISK]▼
Corrigendum to Feb26 notice for Mar28 EGM highlights potential procedural slips, EPS dilution risks from swap
- Ansal Properties/Project Scope↓[MEDIUM RISK]▼
CIRP limited to Lucknow/Rajasthan/Fernhill post-NCLAT Jan2026/Jan2023 orders, but Serene approved Oct2025 leaves uncertainty
Opportunities(8)
- K.M. Sugar Mills/Demerger Listing↓(OPPORTUNITY)◆
Distillery spin-off (Ethanol/ENA) into KM Spirits with Apr1 2026 appointed date, 1:5 ratio unlocks value vs integrated ops
- Lactose India/Capacity Expansion↓(OPPORTUNITY)◆
VIPL merger boosts pharma lactose capacity +50% to 15,000 MT p.a., synergies outweigh modest revenue growth
- Charms Industries/BS Cleanup↓(OPPORTUNITY)◆
Capital reduction wipes losses, reduces face value for potential relisting/liquidity post-NCLT approval
- Torrent Pharmaceuticals/Merger Scale↓(OPPORTUNITY)◆
JB Chemicals amalgamation (NCLT Mar23 order), joint valuation/fairness reports (Jun2025) for larger pharma footprint
- Refex Industries/Green Mobility↓(OPPORTUNITY)◆
Composite scheme creates Refex Mobility, leverages green energy pivot amid EV push
- Ansal Properties/CIRP Progress↓(OPPORTUNITY)◆
50th COC expense ratification + project confinements signal path to resolution plans like Serene (approved Oct2025)
- K.M. Sugar Mills/Shareholder Value↓(OPPORTUNITY)◆
100% consents + no-objections enable efficient demerger, sharper distillery focus vs sugar ops
- Lactose India/Synergies↓(OPPORTUNITY)◆
Despite VIPL losses, merger promises operational efficiencies in pharma ingredients post-EGM Mar28
Sector Themes(6)
- Restructuring Approvals Momentum◆
4/7 filings (KMSugar, Charms, Torrent, Refex) show NCLT approvals/applications in Mar2026, high consents (96-100%) imply low contest risk + faster execution [Positive for turnaround plays]
- Pharma/Chemicals Consolidation◆
3/7 (Lactose x2, Torrent) focus mergers/demergers for capacity (+50% Lactose) but mixed financials (Lactose PAT -24% YoY, VIPL losses) [Synergies vs dilution trade-off]
- High Stakeholder Alignment◆
96-100% consents across KMSugar/Charms/Lactose equity/unsecured/creditors exceeds typical thresholds, reduces scheme failure odds [Bullish resolution signal]
- Legacy Loss Wipeouts◆
Charms/KMSugar address P&L debits/capital mismatches via reduction/demerger, common in post-IBC cleanups [BS strengthening trend]
- Prolonged IBC in Realty◆
Ansal's 50th COC (CIRP since 2022) vs swift schemes elsewhere highlights sector distress vs manufacturing agility [Realty laggard]
- Neutral Sentiment Dominance◆
5/7 neutral (materiality 8-9/10), 1 positive (KMSugar), 1 mixed (Lactose), reflects procedural progress over fundamentals [Watch catalysts]
Watch List(7)
Monitor Mar28 2026 VC/OAVM outcome on VIPL amalgamation, dilution/EPS risks + capacity synergies [Mar28 2026]
Apr28 2026 e-voting (Apr24-27) for JB Chemicals merger post-NCLT Mar23 order [Apr28 2026]
Track Apr1 2026 demerger effective date, listing timeline for KM Spirits distillery [Apr1 2026]
Follow-up on Mar26 2026 Chennai application for green mobility scheme [Post-Mar2026]
Next COC post-50th Mar23 meeting, expense trends + resolution plan for Fernhill [Ongoing 2026]
Implementation of capital reduction (face value to ₹1), creditor settlements ₹51L [Q2 2026]
EGM notice compliance (published Mar27), any shareholder pushback on promoter dilution [Mar28 2026]
Filing Analyses(7)
27-03-2026
The NCLT Allahabad Bench approved the first motion on March 24, 2026, for the scheme of arrangement under Sections 230-232 of the Companies Act, 2013, involving the demerger of the Distillery Division (manufacturing Rectified Spirit, Ethanol, Country Liquor, and ENA) from K M Sugar Mills Limited into its wholly-owned subsidiary KM Spirits and Allied Industries Limited, with an appointed date of April 1, 2026. The demerger seeks to unlock shareholder value through independent listing of the resulting company, sharper focus on distinct business dynamics, and enhanced operational efficiency, with board approvals on August 7, 2025, and no-objection letters from NSE (Jan 12, 2026) and BSE (Jan 13, 2026). Dispensation of certain meetings was allowed, with high consent levels including 96.23% from secured creditors of the demerged company.
- ·Share Entitlement Ratio: 1 equity share of Rs. 10 face value in Resulting Company for every 5 equity shares of Rs. 2 face value in Demerged Company.
- ·No secured creditors in Resulting Company.
- ·100% consent from equity shareholders (Resulting Company) and unsecured creditors (both companies).
- ·Audited financials for year ended 31.03.2025 and provisional as on 30.09.2025 filed.
- ·Valuation report and fairness opinion dated 07.08.2025.
27-03-2026
Lactose (India) Limited issued a corrigendum to the EGM notice dated February 26, 2026, for the scheme of amalgamation with Vitanosh Ingredients Private Limited (VIPL), disclosing an increase in promoter/promoter group shareholding from 53.65% to 58.84% (+5.19%), resulting in public shareholding dilution from 46.35% to 41.16%. LIL's FY25 revenue grew modestly 2.2% YoY to ₹11,639.93 lakhs with EBITDA at ₹1,841.22 lakhs, but PAT declined 24% to ₹516.29 lakhs; meanwhile, VIPL reported deepening losses with PAT at ₹(195.57) lakhs and revenue at ₹34.69 lakhs. The merger promises capacity expansion from 10,000 MT to 15,000 MT p.a. and synergies, but highlights risks like integration challenges, business disruptions, and EPS dilution via 0.7946:1 swap ratio.
- ·Share swap ratio: 0.7946 LIL shares for every 1 VIPL share.
- ·EGM scheduled for March 28, 2026 via VC/OAVM.
- ·VIPL total shares considered for promoter classification: 20,00,000.
- ·LIL Authorized Share Capital: 15,000,000 equity shares of ₹10 each.
- ·Post-merger, LIL total assets increase to ₹14,727.19 lakhs from ₹13,781.42 lakhs.
27-03-2026
Lactose (India) Ltd. disclosed newspaper cuttings of a corrigendum notice for an Extraordinary General Meeting (EGM) scheduled for March 28, 2026, at 10:30 A.M., published in Business Standard (English) and Vadodara Samachar (Gujarati) on March 27, 2026. The notice is also displayed on the company's website www.lactoseindialimited.com, in compliance with SEBI LODR Regulations 30 and 47(3). No specific details on the EGM agenda or financial impacts were provided in the filing.
- ·EGM date and time: Saturday, 28th March 2026 at 10.30 A.M.
- ·Newspapers: Business Standard (English), Vadodara Samachar (Gujarati), published on 27th March 2026.
- ·Scrip Code: 524202
- ·Website: www.lactoseindialimited.com
27-03-2026
The NCLT Ahmedabad Bench approved Charms Industries Ltd's scheme for reduction of paid-up equity share capital from ₹4,10,61,000 (41,06,100 shares of ₹10 each) to ₹41,06,100 (41,06,100 shares of ₹1 each), along with cancellation of capital reserve of ₹31,46,530, to adjust a debit balance of ₹4,01,01,430 in the Profit & Loss account due to capital unrepresented by tangible assets. The scheme received board approval on July 1, 2023, BSE observation on July 1, 2024, and overwhelming shareholder approval at the AGM on September 23, 2024 (25 of 26 members in favor, public shareholders votes in favor exceeding against). No secured creditors exist, while 4 unsecured creditors hold claims of ₹51,22,034; regulators including RD, ROC, IT Dept, and SEBI raised no objections.
- ·No secured creditors as of 30.11.2024.
- ·Company ceased money changing business after RBI license cancellation on 01.07.2021.
- ·Previously on MCA watch list for vanishing companies but regularly filing returns and statements for past five years.
27-03-2026
The 50th Meeting of the Committee of Creditors (COC) for Ansal Properties and Infrastructure Limited's Fernhill Project in Gurugram, Haryana, held on March 23, 2026, approved ratification of expenses incurred during the CIRP period till March 15, 2026, and the fee payable to Ms. Aakriti Sood, Authorised Representative of homebuyer financial creditors. The company's CIRP has been confined by NCLAT order dated January 7, 2026, to Lucknow and Rajasthan projects (per settlement with IL&FS), and Serene Residency project whose resolution plan was approved by NCLT on October 6, 2025. Fernhill Project continues under Resolution Professional Shri Jalesh Kumar Grover.
- ·Prior intimation for 50th COC meeting submitted on March 19, 2026.
- ·NCLAT order dated January 13, 2023, confining Section 7 application to Fernhill Project.
- ·Original CIRP admission by NCLT on November 16, 2022.
- ·Settlement agreement dated March 3, 2022, between IL&FS and APIL.
- ·Voting end date for 50th COC meeting: March 27, 2026.
27-03-2026
Torrent Pharmaceuticals Limited has issued a notice convening an equity shareholders' meeting on April 28, 2026, via VC/OAVM, to consider and approve the Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (Transferor Company) with Torrent Pharmaceuticals Limited (Transferee Company), pursuant to NCLT Ahmedabad Bench order dated March 23, 2026. Remote e-voting opens April 24, 2026, at 9:00 a.m. IST and ends April 27, 2026, at 5:00 p.m. IST, with cut-off date April 21, 2026; financial statements for quarter and nine months ended December 31, 2025, along with valuation reports and fairness opinions, are annexed but show no specific performance variances in the notice.
- ·Tribunal Order dated March 23, 2026 in Company Application No. CA(CAA)/6(AHM)2026.
- ·Joint Share Exchange Ratio Report dated June 29, 2025 by Ernst & Young Merchant Banking Services LLP and BDO Valuation Advisory LLP.
- ·Fairness Opinions dated June 29, 2025 by Axis Capital Limited and ICICI Securities Limited.
- ·Observation letters from BSE and NSE dated February 17, 2026.
- ·Nil Complaint Reports submitted to BSE and NSE in 2025.
27-03-2026
Refex Industries Limited filed a Company Application on March 26, 2026, before the Hon’ble National Company Law Tribunal (NCLT), Chennai Bench, seeking directions for the proposed Composite Scheme of Amalgamation and Arrangement involving Refex Green Mobility Limited (Transferor Company), Refex Industries Limited (Transferee/Demerged Company), and Refex Mobility Limited (Resulting Company). This follows earlier intimations dated September 22, 2025, and March 17, 2026, under Sections 230-232 of the Companies Act, 2013. The disclosure complies with Regulation 30 of SEBI Listing Regulations.
- ·Application filed before NCLT Chennai Bench
- ·Security Code: 532884; Symbol: REFEX
- ·Disclosure dated March 27, 2026
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 7 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 26, 2026
India Stock Market Daily Regulatory Digest — March 26, 2026
India Stock Market Daily Regulatory Digest